Metagenomi, Inc. Common Stock (MGX) earnings · rev $25.2M
These earnings events as JSON? API free 100/dayMetagenomi, Inc. Common Stock (MGX) is a biotechnology company listed on NASDAQ.
This MGX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported MGX revenue for 2025-12-31 was $25.2M. Net income was -$87.9M. Revenue was down 51.8% from 2024-12-31 to 2025-12-31. MGX currently screens at market cap $44.4M.
When the next MGX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 51.8% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full MGX research stays on the stock page; the tape stays on the quote page.
MGX earnings FAQ
What are MGX's latest revenue and net income?
Latest cached Metagenomi, Inc. Common Stock (MGX) revenue for Dec 31, 2025 was $25.2M. Net income was -$87.9M. Statements: https://lician.com/financials/mgx
What is MGX's latest diluted EPS?
Latest cached Metagenomi, Inc. Common Stock (MGX) diluted EPS for Dec 31, 2025 was -$2.36.
What period does the latest MGX earnings print cover?
The latest cached Metagenomi, Inc. Common Stock (MGX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did MGX revenue change from the prior cached period?
Cached Metagenomi, Inc. Common Stock (MGX) revenue was down 51.8% from $52.3M (Dec 31, 2024) to $25.2M (Dec 31, 2025). Statements: https://lician.com/financials/mgx
Where are MGX earnings listed?
Cached earnings facts for Metagenomi, Inc. Common Stock (MGX) are listed at https://lician.com/earnings/mgx. Statements: https://lician.com/financials/mgx
Not investment advice.